Objective: The objective of the study was to evaluate whether anti-Müllerian hormone (AMH)
is associated with fecundability among women with proven fecundity and a history of …

Background: Serum anti‐Mullerian hormone (AMH) is an established marker of the number
of oocytes left within a woman's ovaries (quantitative ovarian reserve). However, it is …

Objective Serum AMH levels are routinely used to predict an individual's response to
controlled ovarian stimulation. The association between AMH and live birth is controversial …

Purpose Anti-Müllerian hormone (AMH) is a biomarker reflecting ovarian reserve. A low
AMH level before 39 years may be associated with a risk of menopause between 40 and 45 …

Background Anti‐Mϋllerian hormone (AMH) plays an important role regulating ovarian
sensitivity to follicle‐stimulating hormone and luteinizing hormone in folliculogenesis. Anti …

Objective Diminished ovarian reserve (DOR) describes women of reproductive age whose
response to ovarian stimulation or fecundity is reduced as compared to women of similar …

This study determined whether anti-Müllerian hormone (AMH) concentration influences the
time necessary to conceive a live-born child–effective time to pregnancy (eTTP)–in a …

Objective To evaluate if antimüllerian hormone (AMH) is associated with pregnancy loss.
Design Prospective cohort study within a block-randomized, double-blind, placebo …

However, the article by Romanski et al.(1) gives us hope, or rather, it reinforces what many
of us already tell our patients: AMH is just one of many measures and is most relevant as a …

Objective To characterize normative antimüllerian hormone (AMH) levels and ascertain
which factors are associated with AMH in a large cohort of reproductive-age women. Design …